Clinigen Group PLC

Clinigen Group PLC
Stock Exchange Other OTC
EPS
$0.27
Market Cap
-
Shares Outstanding
115.37 M
Public Float
-
Clinigen Group PLC
Stock Exchange London Stock Exchange
EPS
GBP20.07
Market Cap
GBP1.3 B
Shares Outstanding
132.48 M
Public Float
119.37 M

Profile

Address
Pitcairn House
Burton-on-Trent Staffordshire DE14 2WW
United Kingdom
Employees -
Website http://clinigen.co.uk
Updated 07/08/2019
Clinigen Group Plc engages in the provision of pharmaceutical products and services. It operates through the following segments: Clinigen Clinical Trial Services (CTS), Idis Managed Access (MA), Idis Global Access (GA), Clinigen Specialty Pharmaceuticals (SP), and Link Health Care. The Clinigen CTS segment sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies.

Financials

View All
Created with Highcharts 5.0.14Clinigen Group PLCNet Income. Fiscal year is July-June. All values GBP Thousands.11 33211 33216 21316 2135 7005 70013 50013 5003 8003 80027 40027 40020132014201520162017201805k10k15k20k25k30k
Created with Highcharts 5.0.14Clinigen Group PLCSales/Revenue. Fiscal year is July-June. All values GBP Thousands.122 580122 580126 639126 639184 400184 400339 900339 900302 300302 300381 200381 2002013201420152016201720180100k200k300k400k500k

Shaun Edward Chilton
Executive Director & Group Deputy CEO
Martin Abell
Chief Financial Officer & Executive Director